共有 50 笔近期内部人交易记录记录,涉及 Ampio Pharmaceuticals, Inc. (AMPE), 包括 32 笔买入 和 15 笔卖出. 内部人买入总额为 $2.87M 内部人卖出总额为 $481.19K.
近期活跃的重要内部人包括 Buchi J Kevin, Martino Michael A, Stevens David R. 内部人交易记录可以揭示公司管理层对股票估值和未来前景的看法.
内部人交易记录 — AMPE
| 日期 |
姓名 |
职位 |
交易类型 |
股数 |
平均价格 |
总价值 |
持股数量 |
| 2023-06-09 |
Buchi J Kevin |
Director |
知情买入 |
21,858 |
$0.29 |
$6.28K |
146,858 |
| 2023-06-08 |
Buchi J Kevin |
Director |
知情买入 |
25,000 |
$0.30 |
$7.4K |
125,000 |
| 2023-05-24 |
Martino Michael A |
CEO |
知情买入 |
76,890 |
$0.29 |
$22.12K |
76,890 |
| 2023-05-16 |
Buchi J Kevin |
Director |
知情买入 |
32,534 |
$0.27 |
$8.92K |
100,000 |
| 2023-05-15 |
Buchi J Kevin |
Director |
知情买入 |
44,026 |
$0.25 |
$10.86K |
67,466 |
| 2023-05-12 |
Stevens David R |
Director |
知情买入 |
45,000 |
$0.22 |
$9.9K |
103,971 |
| 2023-05-12 |
Buchi J Kevin |
Director |
知情买入 |
23,440 |
$0.24 |
$5.51K |
23,440 |
| 2023-05-11 |
Stevens David R |
Director |
知情买入 |
25,000 |
$0.22 |
$5.5K |
33,971 |
| 2022-03-01 |
Jobes Elizabeth Varki |
Director |
限制性股票授予 (RSU) |
150,000 |
$0.45 |
$67.7K |
150,000 |
| 2022-02-09 |
Bar-or David |
Director |
限制性股票授予 (RSU) |
75,000 |
$0.53 |
$39.71K |
75,000 |
| 2022-02-08 |
Jobes Elizabeth Varki |
Officer |
未知 |
- |
- |
- |
- |
| 2022-01-01 |
Martino Michael A |
Interim Chairman and CEO |
限制性股票授予 (RSU) |
250,000 |
$0.57 |
$142.5K |
250,000 |
| 2022-01-01 |
Macaluso Michael |
Director |
RSU 预扣税 |
68,400 |
$0.57 |
$38.99K |
2,624,882 |
| 2022-01-01 |
Stokely Dan |
CFO |
RSU 预扣税 |
22,914 |
$0.57 |
$13.06K |
312,274 |
| 2022-01-01 |
Cherevka Holli |
President and COO |
RSU 预扣税 |
47,200 |
$0.57 |
$26.9K |
410,820 |
| 2021-12-30 |
Coelho Philip H |
Director |
限制性股票授予 (RSU) |
75,000 |
$0.56 |
$42K |
75,000 |
| 2021-12-30 |
Buchi J Kevin |
Director |
限制性股票授予 (RSU) |
75,000 |
$0.56 |
$42K |
75,000 |
| 2021-12-30 |
Stevens David R |
Director |
限制性股票授予 (RSU) |
75,000 |
$0.56 |
$42K |
75,000 |
| 2021-12-30 |
Giles Richard B |
Director |
限制性股票授予 (RSU) |
75,000 |
$0.56 |
$42K |
75,000 |
| 2021-11-22 |
Martino Michael A |
Interim Chairman and CEO |
限制性股票授予 (RSU) |
750,000 |
$1.14 |
$855K |
750,000 |
| 2021-10-27 |
Macaluso Michael |
CEO |
RSU 预扣税 |
43,470 |
$1.64 |
$71.29K |
2,693,282 |
| 2021-10-27 |
Stokely Dan |
CFO |
RSU 预扣税 |
28,127 |
$1.64 |
$46.13K |
335,188 |
| 2021-10-27 |
Cherevka Holli |
President and COO |
RSU 预扣税 |
41,980 |
$1.64 |
$68.85K |
458,020 |
| 2021-10-21 |
Buchi J Kevin |
Director |
限制性股票授予 (RSU) |
150,000 |
$1.67 |
$250.5K |
150,000 |
| 2021-10-21 |
Martino Michael A |
Director |
限制性股票授予 (RSU) |
150,000 |
$1.67 |
$250.5K |
150,000 |
| 2021-10-13 |
Coelho Philip H |
Director |
限制性股票授予 (RSU) |
120,000 |
$1.67 |
$200.4K |
120,000 |
| 2021-10-13 |
Stevens David R |
Director |
限制性股票授予 (RSU) |
120,000 |
$1.67 |
$200.4K |
120,000 |
| 2021-10-13 |
Giles Richard B |
Director |
限制性股票授予 (RSU) |
120,000 |
$1.67 |
$200.4K |
120,000 |
| 2021-10-13 |
Bar-or David |
Director |
限制性股票授予 (RSU) |
120,000 |
$1.67 |
$200.4K |
120,000 |
| 2021-10-13 |
Buchi J Kevin |
Officer |
未知 |
- |
- |
- |
- |
| 2021-10-13 |
Martino Michael A |
Officer |
未知 |
- |
- |
- |
- |
| 2021-10-11 |
Macaluso Michael |
CEO |
限制性股票授予 (RSU) |
950,000 |
- |
- |
2,736,752 |
| 2021-10-11 |
Stokely Dan |
CFO |
限制性股票授予 (RSU) |
335,000 |
- |
- |
363,315 |
| 2021-10-11 |
Cherevka Holli |
Chief Operating Officer |
限制性股票授予 (RSU) |
500,000 |
- |
- |
500,000 |
| 2021-06-25 |
Stokely Dan |
CFO |
知情卖出 |
22,500 |
$1.79 |
$40.28K |
28,315 |
| 2021-05-21 |
Coelho Philip H |
Director |
期权行权(卖出) |
6,737 |
$0.40 |
$2.69K |
- |
| 2021-05-21 |
Cherevka Holli |
Chief Operating Officer |
知情卖出 |
2,603 |
$2.00 |
$5.21K |
- |
| 2021-05-18 |
Stokely Dan |
CFO |
知情卖出 |
35,000 |
$1.83 |
$63.98K |
28,315 |
| 2021-05-17 |
Stokely Dan |
CFO |
期权行权 |
35,000 |
$0.43 |
$15.05K |
63,315 |
| 2021-04-29 |
Coelho Philip H |
Director |
期权行权(卖出) |
3,263 |
$0.40 |
$1.31K |
6,737 |
| 2021-04-27 |
Coelho Philip H |
Director |
期权行权(卖出) |
20,000 |
$0.40 |
$8K |
10,000 |
| 2021-04-27 |
Cherevka Holli |
Chief Operating Officer |
期权行权(卖出) |
30,000 |
$0.51 |
$15.3K |
- |
| 2021-03-16 |
Stokely Dan |
CFO |
知情卖出 |
40,000 |
$1.83 |
$73.05K |
28,315 |
| 2021-02-12 |
Stokely Dan |
CFO |
期权行权(卖出) |
10,500 |
$0.59 |
$6.17K |
19,500 |
| 2021-01-04 |
Coelho Philip H |
Director |
限制性股票授予 (RSU) |
13,513 |
$1.48 |
$20K |
203,500 |
| 2021-01-04 |
Stevens David R |
Director |
限制性股票授予 (RSU) |
13,513 |
$1.48 |
$20K |
134,562 |
| 2021-01-04 |
Giles Richard B |
Director |
限制性股票授予 (RSU) |
13,513 |
$1.48 |
$20K |
314,866 |
| 2021-01-04 |
Bar-or David |
Director |
限制性股票授予 (RSU) |
13,513 |
$1.48 |
$20K |
92,800 |
| 2020-12-17 |
Macaluso Michael |
CEO |
限制性股票授予 (RSU) |
50,000 |
$1.78 |
$89K |
50,000 |
| 2020-12-17 |
Stokely Dan |
CFO |
限制性股票授予 (RSU) |
20,000 |
$1.78 |
$35.6K |
20,000 |
■ 知情交易 — 公开市场买卖(最具参考价值)
■ 非知情买入 — 奖励、期权行权、转换
■ 非知情卖出 — 税务代扣、归属出售
■ 中性 — 礼赠、信托、到期